Replimune Group Inc. (REPL) at a glance

Replimune Group Inc. (REPL) is a small-cap Healthcare company. It trades at $15.6, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Momentum (84/100) and its weakest is Income (40/100). Its volatility is roughly in line with the market.

Price

$15.60

Market cap

$733.2M

P/E ratio

n/a

Dividend yield

None

Beta

0.91

52-week range

$1.50 to $16.15